SCHEMBL13005641

SCHEMBL13005641

CC(C)Cc1cccc(CN(Cc2ccccc2OC(F)(F)F)[C@@H](CC(C)C)CN(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.41
SLC6A2 P23975 4/20 0.41
CETP P11597 5/20 0.39
SLC6A3 Q01959 4/20 0.38
LNPEP Q9UIQ6 1/20 0.35
DRD2 P14416 2/20 0.32
KCNH2 Q12809 1/20 0.32
NMT1 P30419 1/20 0.31
PDE9A O76083 1/20 0.31
PDE1A P54750 1/20 0.31
PDE1B Q01064 1/20 0.31
PDE1C Q14123 1/20 0.31
PPARG P37231 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13061125 0.93 SLC6A4 (0.41) SLC6A4SLC6A2CETPSLC6A3LNPEP
SCHEMBL13005616 0.88 BCHE (0.40) SLC6A4SLC6A2CETPSLC6A3CYP2D6
SCHEMBL13005509 0.85 SLC6A4 (0.47) SLC6A4SLC6A2CETPSLC6A3KCNH2
SCHEMBL13005504 0.83 ALDH1A1 (0.36) SLC6A2CETPSLC6A3GRIN2DGRIN3B
SCHEMBL13005518 0.81 CETP (0.40) SLC6A4SLC6A2CETPSLC6A3KCNH2
SCHEMBL13005520 0.81 LMNA (0.37) SLC6A4SLC6A2CETPSLC6A3
SCHEMBL13005507 0.81 TAAR1 (0.34) CETPGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13005500 0.81 GABRA1 (0.39) CETPGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13005522 0.81 CETP (0.36) CETPGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13061124 0.80 ACHE (0.40) SLC6A4SLC6A2SLC6A3CYP2D6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed